Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serious Diseases
– Spin-out of Scorpion Therapeutics, led by former Scorpion Therapeutics management team – – Advancing multiple programs across cancer and other serious diseases; plans to advance first new product candidate into the clinic in 2026…